Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Conditions
Interventions
Etanercept
Placebo
Locations
8
United States
Feinstein Institute for Medical Rsearch
New Hyde Park, New York, United States
Columbia University Medical Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Texas Children's Hospital
Houston, Texas, United States
Primary Children's Medical Center
Salt Lake City, Utah, United States
Seattle Children's Hospital
Seattle, Washington, United States
Start Date
March 1, 2009
Primary Completion Date
January 1, 2018
Completion Date
August 30, 2018
Last Updated
May 6, 2023
NCT07291245
NCT05643651
NCT06993636
NCT01917721
NCT07405658
NCT03861130
Lead Sponsor
Michael Portman
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions